Soluble interleukin-1 receptor type II levels in gingival crevicular fluid in aggressive and chronic periodontitis

Journal of Periodontology

Volumn 79, Issue 3, 2008, Pages 495-500

  Suzuki, M ^a   Ishihara, Y ^a   Kamiya, Y ^a   Koide, M ^b   Fuma, D ^a   Fujita, S ^a   Matsumura, Y ^a   Suga, T ^a   Kamei, H ^a   Noguchi, T ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b MATSUMOTO DENTAL UNIVERSITY   (Japan)

Author keywords

Gingival crevicular fluid; Interleukin 1 beta; Interleukin 1 receptor type II; Periodontitis

Indexed keywords

INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 1BETA;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BIOSYNTHESIS; CHEMISTRY; CHRONIC DISEASE; FEMALE; GINGIVITIS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; OSTEOLYSIS; PATHOLOGY; PERIODONTICS; PERIODONTITIS;

ACUTE DISEASE; ADULT; AGED; ALVEOLAR BONE LOSS; CHRONIC DISEASE; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; PERIODONTAL INDEX; PERIODONTITIS; RECEPTORS, INTERLEUKIN-1 TYPE II;

EID: 41449084583     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070111     Document Type: Article

References (29)

1. Al-Shammari KF, Giannobile WV, Aldredge WA, et al. Effect of non-surgical periodontal therapy on C-telopeptide pyridinoline cross-links (ICTP) and interleukin-1 levels. J Periodontol 2001 ;72:1045-1051.
2. Persson GR, DeRouen TA, Page RC. Relationship between gingival crevicular fluid levels of aspartate aminotransferase and active tissue destruction in treated chronic periodontitis patients. J Periodontal Res 1990;25:81-87.
3. Oringer RJ, Al-Shammari KF, Aldredge WA, et al. Effect of locally delivered minocycline microspheres on markers of bone resorption. J Periodontol 2002;73: 835-842.
4. Ishihara Y, Nishihara T, Kuroyanagi T, et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res 1997;32:524-529.
5. Ohguchi M, Yamato K, Ishihara Y, et al. Activin A regulates the production of mature interleukin-1 ß and interleukin-1 receptor antagonist in human monocytic cells. J Interferon Cytokine Res 1998;18:491-498.
6. Takahashi T, Nishihara T, Ishihara Y, et al. Murine macrophage interleukin-1 release by capsularlike serotype-specific polysaccharide antigens of Actinobacillus actinomycetemcomitans. Infect Immun 1991;59: 18-23.
7. Ishihara Y, Nishihara T, Maki E, et al. Role of interleukin-1 and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetemcomitans lipopolysaccharide. J Periodontal Res 1991;26:155-160.
8. Nishihara T, Ueda N, Amano K, et al. Actinobacillus actinomycetemcomitans Y4 capsular-polysaccharide-like polysaccharide promotes osteoclast-like cell for_mation by interleukin-1 alpha production in mouse marrow cultures. Infect Immun 1995;63:1893-1898.
9. Ueda N, Nishihara T, Ishihara Y, et al. Role of prostaglandin in the formation of osteoclasts induced by capsular-like polysaccharide antigen of Actinobacillus actinomycetemcomitans strain Y4. Oral Microbiol Immunol 1995;10:69-75.
10. Nishihara T, Ishihara Y, Koseki T, et al. Membrane-associated interleukin-1 on macrophages stimulated with Actinobacillus actinomycetemcomitans lipopoly-saccharide induces osteoclastic bone resorption in vivo. Cytobios 1995;81:229-237.
11. Sims JE, Gayle MA, Slack JL, et al. Interleukin-1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA 1993;90:6155-6159.
12. Dinarello CA. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998;16:457-499.
13. Clark W, Jobanputra P, Barton P, et al. The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: A systematic review and economic analysis. Health Technol Assess 2004;8: iii-iv, ix-x, 1-105.
14. Schei O, Waerhaung J, Lovdal A, et al. Alveolar bone loss as related to oral hygiene and age. J Periodontol 1959;30:7-16.
15. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
16. Engebretson SP, Grbic JT, Singer R, et al. GCF IL-1 ß profiles in periodontal disease. J Clin Periodontol 2002; 29:48-53.
17. Lin SJ, Chen YL, Kuo MY, et al. Measurement of gp 130 cytokines-oncostatin M and IL-6 in gingival crevicular fluid of patients with chronic periodontitis. Cytokine 2005;30:160-167.
18. 4 in the gingival crevicular fluid. J Dent 1998;26:97-103.
19. Gupta K, Bewtra A. IL-1 receptor-type expression in relation to atopy. J Allergy Clin Immunol 1999;103: 1100-1107.
20. Jouvenne P, Vannier E, Dinarello CA, et al. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: Correlations with markers of inflammation and joint destruction. Arthritis Rheum 1998;41: 1083-1089.
21. Kharfi A, Akoum A. Soluble interleukin-1 receptor type II blocks monocyte chemotactic protein-1 secretion by U937 cells in response to peripheral blood serum of women with endometriosis. Fertil Steril 2002; 78:836-842.
22. Bourke E, Cassetti A, Villa A, et al. IL-1ß scavenging by the type II IL-1 decoy receptor in human neutrophils. J Immunol 2003;170:5999-6005.
23. Colotta F, Re F, Muzio M, et al. Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J Biol Chem 1994; 269:12403-12406.
24. Colotta F, Re F, Muzio M, et al. Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4. Science 1993;261:472-475.
25. Dickensheets HL, Donnelly RP. IFN-γ and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes. J Immunol 1997;159:6226-6233.
26. van Schie RC, Wilson ME. Evaluation of human FcγRIIA (CD32) and FcγRIIIA (CD 16) polymorphisms in Caucasians and African-Americans using salivary DNA. Clin Diagn Lab Immunol 2000;7:676-681.
27. Lu H, Califano JV, Schenkein HA, et al. Immunoglobulin class and subclass distribution of antibodies reactive with the immunodominant antigen of Actinobacillus actino-mycetemcomitans serotype b. Infect Immun 1993;61: 2400-2407.
28. Kikuchi T, Willis DL, Liu M, et al. Dendritic-NK cell interactions in P. gingivalis-specific responses. J Dent Res 2005;84:858-862.
29. Barbour SE, Ishihara Y, Fakher M. Monocyte differentiation in localized juvenile periodontitis is skewed toward the dendritic cell phenotype. Infect Immun 2002; 70:2780-2786.